- Efficacy of clodronate(ostac) on bone metastases in malignancy
-
Kim JH, Lim HY, Yoo NC, Rah SY, Choi JH, Koh EH, Roh JK, Kim BS
- KMID: 1694294
- J Korean Cancer Assoc.
- 1993 Feb;25(1):85-91.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+increase are reciprocally modulated in rat cardiomyocytes
-
Kim SY, Kim SJ, Kim BJ, Rah SY, Chung SM, Im MJ, Kim UH
- KMID: 1098088
- Exp Mol Med.
- 2006 Oct;38(5):535-545.
Doxorubicin (DOX) is one of the most potent anticancer drugs and induces acute cardiac arrhythmias and chronic cumulative cardiomyopathy. Though DOX-induced cardiotoxicity is known to be caused mainly by ROS... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Study on the Etiology and the Characteristics of Pleural Effusion in Children
-
Jeong JH, Rah SY, Sun YH, Lee MH, Koh YY
- KMID: 2208048
- J Korean Pediatr Soc.
- 1998 Jan;41(1):62-73.
PURPOSE: Many different conditions result in pleural effusions (PEs) and making the differential diagnosis of PE is difficult. The purpose of the present study was to document the change of... -
- CITED
-
- Close
- SHARE
-
- Close
- Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose
-
Nam TS, Choi SH, Rah SY, Kim SY, Jang W, Im MJ, Kwon HJ, Kim UH
- KMID: 1115950
- Exp Mol Med.
- 2006 Dec;38(6):718-726.
ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP- ribose (cADPR), from beta-NAD+. A prototype of mammalian ADPR-cyclases is a lymphocyte antigen CD38. Accumulating evidence indicates that ADPR-cyclases other... -
- CITED
-
- Close
- SHARE
-
- Close
- Plasma TGF-beta1 as a Tumor Marker in Breast Cancer Patients
-
Lee HY, Rah SY, Gong SJ, Ahn JB, Shim KY, Park JO, Kwon HJ, Yoo NC, Jeong SJ, Chung HC, Kim JH, Lee KS, Min JS, Kim BS, Roh JK
- KMID: 2175334
- J Korean Cancer Assoc.
- 1998 Oct;30(5):935-942.
PURPOSE: Transforming Growth Factor-beta1(TGF-beta1) is the most potent inhibitor of the progression of normal mammary epithelial cells through the cell cycle. However, advanced breast cancers are mostly refractory to TGF-beta... -
- CITED
-
- Close
- SHARE
-
- Close
- GEnetic Change in Transforming Growth Factor-B (TGF-B) Receptor Type I and Type II Genes with Resistance to TGF-B of Human Breast Cancer Cells
-
Lee HY, Jeon SS, Kwon HJ, Kong SJ, Rah SY, Ahn JB, Sim KY, Yoo NC, Kim JH, Roh JK, Lee KS, Min JS, Kim BS, Chung HC
- KMID: 2006861
- J Korean Cancer Assoc.
- 1998 Aug;30(4):683-691.
PURPOSE: Transforming growth factor-Bs (TGF-Bs) are prototypic multifunctional negative growth factors that inhibit the growth of many cell types. TGF-B type I and II receptors(RI, RII) are transmembrane receptors containing... -
- CITED
-
- Close
- SHARE
-
- Close
